Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · SAINT ALBANS, WV · NPI 1497195374
Verified facts
CMS Open Payments records show Rita Ramesh Patel, M.D. received $17.53 in general payments during 2025 across 1 reported records.
Organon LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Organon LLC | Unresolved — no canonical attribution shown | $17.53 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.53 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NEXPLANON Normalized: nexplanon |
Drug | Organon LLC | $17.53 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 269 | 79 |
| Levothyroxine Sodium | Levothyroxine Sodium | 241 | 71 |
| Metoprolol Succinate | Metoprolol Succinate | 213 | 69 |
| Amlodipine Besylate | Amlodipine Besylate | 211 | 68 |
| Losartan Potassium | Losartan Potassium | 197 | 64 |
| Gabapentin | Gabapentin | 194 | 42 |
| Pantoprazole Sodium | Pantoprazole Sodium | 186 | 60 |
| Metformin Hcl | Metformin Hcl | 170 | 51 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 169 | 60 |
| Simvastatin | Simvastatin | 151 | 43 |
| Lisinopril | Lisinopril | 148 | 49 |
| Pravastatin Sodium | Pravastatin Sodium | 135 | 42 |
| Montelukast Sodium | Montelukast Sodium | 134 | 39 |
| Meloxicam | Meloxicam | 116 | 42 |
| Furosemide | Furosemide | 115 | 44 |
| Ozempic | Semaglutide | 114 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 107 | 44 |
| Omeprazole | Omeprazole | 96 | 35 |
| Hydrochlorothiazide | Hydrochlorothiazide | 91 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 87 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 83 | 27 |
| Tizanidine Hcl | Tizanidine Hcl | 83 | 27 |
| Alprazolam | Alprazolam | 77 | 12 |
| Ezetimibe | Ezetimibe | 75 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 71 | 20 |
| Jardiance | Empagliflozin | 71 | 30 |
| Glimepiride | Glimepiride | 69 | 19 |
| Tramadol Hcl | Tramadol Hcl | 69 | 15 |
| Metoprolol Tartrate | Metoprolol Tartrate | 68 | 19 |
| Pregabalin | Pregabalin | 68 | 16 |
| Methylprednisolone | Methylprednisolone | 66 | 51 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 65 | 32 |
| Famotidine | Famotidine | 62 | 20 |
| Potassium Chloride | Potassium Chloride | 61 | 20 |
| Trazodone Hcl | Trazodone Hcl | 60 | 21 |
| Allopurinol | Allopurinol | 58 | 20 |
| Metformin Hcl Er | Metformin Hcl | 56 | 18 |
| Sertraline Hcl | Sertraline Hcl | 55 | 20 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 55 | 15 |
| Clonazepam | Clonazepam | 52 | suppressed |
| Eliquis | Apixaban | 50 | 20 |
| Carvedilol | Carvedilol | 48 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 46 | 16 |
| Tamsulosin Hcl | Tamsulosin Hcl | 45 | 15 |
| Januvia | Sitagliptin Phosphate | 44 | 11 |
| Synthroid | Levothyroxine Sodium | 44 | 11 |
| Lorazepam | Lorazepam | 43 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 41 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 41 | 18 |
| Zolpidem Tartrate | Zolpidem Tartrate | 40 | 11 |
| Azelastine Hcl | Azelastine Hcl | 39 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 39 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Atenolol | Atenolol | 36 | 11 |
| Clonidine Hcl | Clonidine Hcl | 35 | 15 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 33 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 31 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 28 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 27 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 27 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 21 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 25 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 25 | suppressed |
| Celecoxib | Celecoxib | 24 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 23 | 21 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 23 | suppressed |
| Ramipril | Ramipril | 23 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 22 | 15 |
| Buspirone Hcl | Buspirone Hcl | 22 | suppressed |
| Carbamazepine | Carbamazepine | 21 | suppressed |
| Chlorthalidone | Chlorthalidone | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 21 | suppressed |
| Trulicity | Dulaglutide | 21 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 20 | suppressed |
| Entresto | Sacubitril/Valsartan | 20 | suppressed |
| Ondansetron Odt | Ondansetron | 20 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 20 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | suppressed |
| Dutasteride | Dutasteride | 19 | suppressed |
| Fluconazole | Fluconazole | 19 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 19 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 18 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 18 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 18 | suppressed |
| Torsemide | Torsemide | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Nystatin | Nystatin | 17 | suppressed |
| Spironolactone | Spironolactone | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | 13 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 16 | suppressed |
| Linzess | Linaclotide | 16 | suppressed |
| Vascepa | Icosapent Ethyl | 16 | suppressed |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Mirtazapine | Mirtazapine | 15 | suppressed |
| Myrbetriq | Mirabegron | 15 | suppressed |
| Prednisone | Prednisone | 15 | 13 |
| Topiramate | Topiramate | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 14 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Azithromycin | Azithromycin | 13 | 12 |
| Diazepam | Diazepam | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 12 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | 11 |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Finasteride | Finasteride | 11 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 11 | suppressed |
| Xarelto | Rivaroxaban | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.53 · 1 records | Organon LLC | NEXPLANON | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error